QUICK SPARK: This New ETF Goes Beyond Eli Lilly, Novo Nordisk and Targets the Peptide Boom
REX Shares has launched the REX Peptide ETF NASDAQ:PEPT, offering exposure to the peptide economy beyond Eli Lilly And Co NYSE:LLY and Novo Nordisk NYSE:NVO, the two drugmakers dominating the GLP-1 market.The ETF tracks the VettaFi Peptide Index, which spans 36 constituents across therapeutics, man…

What's Your Reaction?









